Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 14 hours agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via Yahoo News· 3 hours agoThe state of Kansas filed a lawsuit on Monday against pharmaceutical company Pfizer, alleging the...
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 9 hours agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
Wichita Eagle via Yahoo News· 11 hours agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it...
Kansas AG Kris Kobach suing Pfizer for ‘misleading Kansans on COVID vaccine’
KWCH· 12 hours agoKansas Attorney General Kris Kobach announced that he’s suing Pfizer “for misleading claims it made...
Grace Hills, Kansas Reflector
The Raw Story· 26 minutes agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company Pfizer, alleging that “Pfizer misled the public that it ...
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
Gannett via AOL· 13 hours agoKansas Attorney General Kris Kobach is suing Pfizer over its COVID-19 vaccine, alleging the company...
Pfizer Inc. (NYSE:PFE) Stake Boosted by Wellington Management Group LLP
ETF DAILY NEWS· 22 hours agoWellington Management Group LLP lifted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure ...
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 21 hours agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Market Watch· 8 hours ago“We’ll provide protection that’s broader than anything that’s out there,” Art Hirt, senior vice...
